Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.

Yan L, Zhang JD, Wang B, Lv YJ, Jiang H, Liu GL, Qiao Y, Ren M, Guo XF.

PLoS One. 2013 Sep 10;8(9):e72548. doi: 10.1371/journal.pone.0072548. eCollection 2013.

2.

Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.

Peng F, Lin J, Lin L, Tang H.

Int J Mol Med. 2012 Dec;30(6):1376-86. doi: 10.3892/ijmm.2012.1153. Epub 2012 Oct 9.

PMID:
23064712
3.
4.

Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation.

Meng Z, Yu XH, Chen J, Li L, Li S.

Acta Pharmacol Sin. 2014 Oct;35(10):1247-56. doi: 10.1038/aps.2014.63. Epub 2014 Aug 18.

5.

Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.

Yin Z, Wang X, Zhang L, Zhou H, Wei L, Dong X.

Cardiovasc Ther. 2016 Feb;34(1):21-9. doi: 10.1111/1755-5922.12164.

PMID:
26506219
6.

Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload.

Ruzicska E, Foldes G, Lako-Futo Z, Sarman B, Wellmann J, Szenasi G, Tulassay Z, Ruskoaho H, Toth M, Somogyi A.

J Hypertens. 2004 Jun;22(6):1191-200.

PMID:
15167455
7.

3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.

Zong J, Wu QQ, Zhou H, Zhang JY, Yuan Y, Bian ZY, Deng W, Dai J, Li FF, Xu M, Fang Y, Tang QZ.

Mol Med Rep. 2015 Jul;12(1):1247-52. doi: 10.3892/mmr.2015.3523. Epub 2015 Mar 20.

PMID:
25816057
8.

Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.

Essick EE, Ouchi N, Wilson RM, Ohashi K, Ghobrial J, Shibata R, Pimentel DR, Sam F.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H984-93. doi: 10.1152/ajpheart.00428.2011. Epub 2011 Jun 10.

9.

Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.

Chen G, Pan SQ, Shen C, Pan SF, Zhang XM, He QY.

Acta Pharmacol Sin. 2014 Apr;35(4):463-75. doi: 10.1038/aps.2013.185. Epub 2014 Mar 10.

10.

Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.

Ye Y, Mou Y, Bai B, Li L, Chen GP, Hu SJ.

Int J Biochem Cell Biol. 2010 Dec;42(12):2056-64. doi: 10.1016/j.biocel.2010.09.010. Epub 2010 Sep 25.

PMID:
20884373
11.

Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.

Zhang ZZ, Shang QH, Jin HY, Song B, Oudit GY, Lu L, Zhou T, Xu YL, Gao PJ, Zhu DL, Penninger JM, Zhong JC.

J Transl Med. 2013 Sep 25;11:229. doi: 10.1186/1479-5876-11-229.

12.

Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy.

Wu QQ, Zong J, Gao L, Dai J, Yang Z, Xu M, Fang Y, Ma ZG, Tang QZ.

Herz. 2014 May;39(3):390-6. doi: 10.1007/s00059-013-3849-4. Epub 2013 Jun 21.

PMID:
23784363
13.

JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.

Hilfiker-Kleiner D, Hilfiker A, Castellazzi M, Wollert KC, Trautwein C, Schunkert H, Drexler H.

Cardiovasc Res. 2006 Jul 1;71(1):108-17. Epub 2006 Mar 7.

PMID:
16690042
14.
15.

[PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats].

Chen HJ, Chen JZ, Wang XX, Yu M.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Sep;36(5):470-6. Chinese.

PMID:
17924466
16.

Inhibition of cardiac hypertrophy by probiotic-fermented purple sweet potato yogurt in spontaneously hypertensive rat hearts.

Lin PP, Hsieh YM, Kuo WW, Lin CC, Tsai FJ, Tsai CH, Huang CY, Tsai CC.

Int J Mol Med. 2012 Dec;30(6):1365-75. doi: 10.3892/ijmm.2012.1154. Epub 2012 Oct 12.

PMID:
23064753
17.

Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats.

Wang H, Jessup JA, Lin MS, Chagas C, Lindsey SH, Groban L.

Cardiovasc Res. 2012 Apr 1;94(1):96-104. doi: 10.1093/cvr/cvs090. Epub 2012 Feb 10.

18.

Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.

Magga J, Kalliovalkama J, Romppanen H, Vuolteenaho O, Pörsti I, Kähönen M, Tolvanen JP, Ruskoaho H.

J Hypertens. 1999 Nov;17(11):1543-52.

PMID:
10608466
19.

Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.

Irukayama-Tomobe Y, Miyauchi T, Sakai S, Kasuya Y, Ogata T, Takanashi M, Iemitsu M, Sudo T, Goto K, Yamaguchi I.

Circulation. 2004 Feb 24;109(7):904-10. Epub 2004 Feb 16.

20.

Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.

Ye P, Yang W, Wu SM, Sheng L.

Methods Find Exp Clin Pharmacol. 2006 Dec;28(10):691-6.

PMID:
17235413

Supplemental Content

Support Center